Acelyrin (SLRN) Stock Forecast, Price Target & Predictions
SLRN Stock Forecast
Acelyrin stock forecast is as follows: an average price target of $10.50 (represents a 142.49% upside from SLRN’s last price of $4.33) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
SLRN Price Target
SLRN Analyst Ratings
Buy
Acelyrin Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 16, 2024 | Derek Archila | Wells Fargo | $15.00 | $5.72 | 162.24% | 246.42% |
Aug 14, 2024 | Samantha Semenkow | Citigroup | $6.00 | $4.06 | 47.78% | 38.57% |
Mar 20, 2024 | Derek Archila | Wells Fargo | $13.00 | $8.32 | 56.25% | 200.23% |
10
Acelyrin Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $15.00 | $11.33 |
Last Closing Price | $4.33 | $4.33 | $4.33 |
Upside/Downside | -100.00% | 246.42% | 161.66% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 16, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Sep 25, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 14, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 14, 2024 | Citigroup | Neutral | Neutral | Hold |
Aug 14, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 14, 2024 | H.C. Wainwright | Buy | Neutral | Downgrade |
Jul 08, 2024 | Wells Fargo | - | Overweight | Upgrade |
May 24, 2024 | Piper Sandler | Overweight | Overweight | Hold |
May 10, 2024 | H.C. Wainwright | Buy | Buy | Hold |
May 30, 2023 | Piper Sandler | - | Overweight | Initialise |
10
Acelyrin Financial Forecast
Acelyrin Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Acelyrin EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Acelyrin Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-134.78M | $-60.90M | $-58.90M | $-60.90M | $-74.88M | $-59.26M | $-52.16M | $-50.05M | $-84.57M | $-79.74M | $-77.35M |
High Forecast | $-134.78M | $-60.90M | $-58.90M | $-60.90M | $-74.88M | $-59.26M | $-52.16M | $-50.05M | $-69.20M | $-79.74M | $-77.35M |
Low Forecast | $-134.78M | $-60.90M | $-58.90M | $-60.90M | $-74.88M | $-59.26M | $-52.16M | $-50.05M | $-98.99M | $-79.74M | $-77.35M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Acelyrin SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
SG&A | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Acelyrin EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-1.35 | $-0.61 | $-0.59 | $-0.61 | $-0.75 | $-0.59 | $-0.52 | $-0.50 | $-0.85 | $-0.80 | $-0.78 |
High Forecast | $-1.35 | $-0.61 | $-0.59 | $-0.61 | $-0.75 | $-0.59 | $-0.52 | $-0.50 | $-0.69 | $-0.80 | $-0.78 |
Low Forecast | $-1.35 | $-0.61 | $-0.59 | $-0.61 | $-0.75 | $-0.59 | $-0.52 | $-0.50 | $-0.99 | $-0.80 | $-0.78 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast